Media Centre
Media Relations
Our experts
Publications and Magazines
Multimedia Library
Screen Rental and Digital Signage
Feature Story
The Big Picture
Contact Us

News from the JGH 
Now viewing news from:
Neurofeedback: an effective placebo treatment?
Dr. Amir Raz argues that this increasingly popular technology treats patients for reasons very different from those commonly assumed.
[Read more]
Long-term limitations imposed on patients with pulmonary embolism
New clinical study, led by the Jewish General Hospital, determines that close to half of patients who suffer a blood clot in their lung will experience exercise limitations at one year
[Read more]
JGH increases public awareness of colorectal cancer
Montreal, March 20, 2017– Colorectal cancer is the third-most common form of cancer in Canada, second only to breast cancer in women and prostate cancer in men. Early screening is essential to improving the chances of a cure.
[Read more]
Free JGH Parking for Patients, Visitors and Staff Today
Due to yesterday's weather conditions, all Jewish General Hospital parking lots will be open and free for all patients, visitors and staff until 4:00 p.m. today, Thursday, March 16, 2017.
[Read more]
Free JGH Parking for Staff and Visitors Today, March 15
Due to current weather conditions, all JGH parking lots will be open and free for all staff and visitors today March 15 until midnight.
[Read more]
Number of people with Alzheimer’s disease world-wide will double between 2030 and 2050
Montreal, January 26, 2017– Research to fight Alzheimer’s disease is continuing relentlessly in the hope that an effective treatment will be found to help the 110,000 people affected in Quebec. “Detecting the cause of the disease remains the number one challenge," says Dr. Andréa C. LeBlanc, Manager of the research laboratory at the Bloomfield Centre on Research in Aging at the Lady Davis Institute at the Jewish General Hospital (JGH). In the following video, Dr. LeBlanc adds, “We expect to see this number double between 2030 and 2050.”
[Read more]
Study concludes that androgen deprivation therapy is not associated with increased risk of Alzheimer disease in patients with prostate cancer
Montreal, January 26, 2017 – A large-scale, population based study led by Dr. Laurent Azoulay, Senior Investigator with the Lady Davis Institute at the Jewish General Hospital, has concluded that the use of androgen deprivation therapy (ADT) to treat advanced prostate cancer is not associated with an increased risk of Alzheimer disease. This result, published in the Journal of Clinical Oncology and accompanied by exclusive coverage by the American Society of Clinical Oncology (ASCO) is important because it soothes f
[Read more]
The fight against tobacco addiction continues: Free services pay off for everyone
Montreal, January 17, 2017– It takes only ten seconds for nicotine to reach the brain, says Mathilde Renaud as a reminder in connection with the 2016-2017 public information campaign, which the Ministry of Health and Social Services has mounted to fight tobacco use. Thus, "the effects of tobacco use, and cigarette addiction in particular, are dramatically quick," notes Ms. Renaud, a counsellor in the Smoking Cessation Centre of the Integrated Health and Social Services University Network for West-Central Montreal (CIUSSS West-Central Montreal).
[Read more]